Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 1 3Phase 2 2Phase 2/3 1Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Esophageal Squamous Cell Carcinoma 6Leukemia 5Esophageal Neoplasms 5Rectal Neoplasms 3Lymphoma 3Head and Neck Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Prostatic Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Oropharyngeal Neoplasms 2Oligodendroglioma 2Nasopharyngeal Carcinoma 2Myelodysplastic Syndromes 2Lung Neoplasms 2Leukemia, T-Cell 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Carcinoma 2Astrocytoma 2Anemia, Refractory, with Excess of Blasts 2Adenocarcinoma Of Esophagus 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Sezary Syndrome 1Sarcoma, Synovial 1Sarcoma, Ewing 1

Interventions

Doxorubicin 2pazopanib 1Trabectedin 1Radiotherapy 1Radiation 1PTC596 1Ifosfamide 1Dacarbazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Leiomyosarcoma × Radiotherapy × Clear all
NCT02180867 2026-05-04

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
140 enrolled 22 charts
Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Granuloma, Plasma Cell, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Chondrosarcoma, Mesenchymal, Dermatofibrosarcoma, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Nerve Sheath Neoplasms, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Perivascular Epithelioid Cell Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡